Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd V.ELXR


Primary Symbol: V.ELXR.H Alternate Symbol(s):  ELIXF

Financial Services Asset Management
Elixxer Ltd. is a Canada-based investment company. The Company has investments and activities in the legal cannabis sector. The Company is focused on investing opportunities in various sectors, with a priority on growth companies that are past the start-up phase.


TSXV:ELXR.H - Post by User

Elixxer Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by Paul1958on Oct 05, 2018 7:43am
90 Views
Post# 28750291

News

Newshttps://www.newswire.ca/news-releases/lgc-capitals-leading-australian-medical-cannabis-lp-partner-little-green-pharma-commences-commercial-sales-to-patients-has-its-products-accepted-for-major-clinical-trials-commences-negotiations-to-export-to-germany-695255531.html

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities